Latest return on equity
CytoMed Therapeutics Return on equity
Direct answer
CytoMed Therapeutics's return on equity is -50.28%.
The verified market snapshot reports -50.28%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked September 12, 2026.
Get free CytoMed Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Return on equity
- -50.28%
Explore related company data
View CytoMed Therapeutics's market capitalizationView CytoMed Therapeutics's price-to-book ratioView CytoMed Therapeutics's 52-week price rangeView CytoMed Therapeutics's revenue growthView CytoMed Therapeutics's profit marginView CytoMed Therapeutics's debt-to-equity ratioView all CytoMed Therapeutics key metricsReturn to CytoMed Therapeutics profile